Director, Business Development
Lincal Accelovance, is an award winning, clinical development Contract Research Organization (CRO) focused on oncology, vaccine, and general medicine Phase I-IV programs. Providing a full complement of global CRO services to pharmaceutical companies and biotechs, Accelovance supports client needs by leveraging operational knowledge and successful results including expertise in study execution, resourcing, pharmacovigilance/safety, site identification, and patient recruitment strategies.